ID   KKU-OCA17
AC   CVCL_M265
DR   Wikidata; Q54900013
RX   PubMed=15884115;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
RX   PubMed=15884115; DOI=10.3748/wjg.v11.i18.2748; PMCID=PMC4305909;
RA   Tepsiri, Nisana
RA   Chaturat, Liengchai
RA   Sripa, Banchob
RA   Namwat, Wises
RA   Wongkham, Sopit
RA   Bhudhisawasdi, Vajarabhongsa
RA   Tassaneeyakul, Wichittra
RT   "Drug sensitivity and drug resistance profiles of human intrahepatic
RT   cholangiocarcinoma cell lines.";
RL   World J. Gastroenterol. 11:2748-2753(2005).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155;
RA   Isidan, Abdulkadir
RA   Yenigun, Ali
RA   Soma, Daiki
RA   Aksu, Eric
RA   Lopez, Kevin
RA   Park, Yujin
RA   Cross-Najafi, Arthur
RA   Li, Ping
RA   Kundu, Debjyoti
RA   House, Michael G.
RA   Chakraborty, Sanjukta
RA   Glaser, Shannon
RA   Kennedy, Lindsey
RA   Francis, Heather
RA   Zhang, Wen-Jun
RA   Alpini, Gianfranco D.
RA   Ekser, Burcin
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//